Omeprazole (API)

Product overview

Omeprazole API from Rraynex is manufactured under WHO-GMP governance with process controls that protect the acid-sensitive benzimidazole structure. High-purity raw materials pass stringent incoming inspection before conversion through controlled synthesis, crystallization, and micronization stages. Inline monitoring tracks pH, particle size, and moisture to keep each batch aligned with IP, BP, USP, and EP specifications. Impurity profiles remain low, supporting downstream formulation into pellets, tablets, or suspensions. We deliver complete technical documentation, including DMF/ASMF summaries, stability data across climatic zones, and validated analytical methods. Packaging is available in nitrogen-flushed fiber drums or smaller lined containers for development work, each qualified for extended transport. Technical teams support method transfer, impurity investigations, and lifecycle change-control. With responsive customer service and global regulatory experience, Rraynex keeps omeprazole API supply secure for partners scaling proton pump inhibitor portfolios.